Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis

C Ciccarese, R Iacovelli, C Porta, G Procopio… - Cancer Treatment …, 2021 - Elsevier
Abstract Background Combinations of PD-1/PD-L1 immune checkpoint inhibitors (ICI) with
VEGFR-TKIs as first-line therapy significantly improve outcomes of metastatic renal cell …
被引用次数：26 相关文章

Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis.

C Ciccarese, R Iacovelli, C Porta… - Cancer Treatment …, 2021 - europepmc.org
Background Combinations of PD-1/PD-L1 immune checkpoint inhibitors (ICI) with VEGFR-
TKIs as first-line therapy significantly improve outcomes of metastatic renal cell carcinoma …

Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis

C Ciccarese, R Iacovelli, C Porta… - Cancer …, 2021 - cancertreatmentreviews.com
Abstract Background Combinations of PD-1/PD-L1 immune checkpoint inhibitors (ICI) with
VEGFR-TKIs as first-line therapy significantly improve outcomes of metastatic renal cell …

Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis

C Ciccarese, R Iacovelli, C Porta… - CANCER …, 2021 - ricerca.uniba.it
Background: Combinations of PD-1/PD-L1 immune checkpoint inhibitors (ICI) with VEGFR-
TKIs as first-line therapy significantly improve outcomes of metastatic renal cell carcinoma …

Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis

C Ciccarese, R Iacovelli, C Porta… - Cancer treatment …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Combinations of PD-1/PD-L1 immune checkpoint inhibitors (ICI) with VEGFR-
TKIs as first-line therapy significantly improve outcomes of metastatic renal cell carcinoma …

Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis

C Ciccarese, R Iacovelli, C Porta… - Cancer …, 2021 - cancertreatmentreviews.com
Abstract Background Combinations of PD-1/PD-L1 immune checkpoint inhibitors (ICI) with
VEGFR-TKIs as first-line therapy significantly improve outcomes of metastatic renal cell …